Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.

He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Teva CEO Talks Drug Pricing, Generics, Supply Shortages

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/7b85f006-296d-44c3-ad3f-b2640105440d/transcript